BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 37516270)

  • 1. First Three Years' Experience of Mucopolysaccharidosis Type-I Newborn Screening in California.
    Fillman T; Matteson J; Tang H; Mathur D; Zahedi R; Sen I; Bishop T; Neogi P; Feuchtbaum L; Olney RS; Sciortino S
    J Pediatr; 2023 Dec; 263():113644. PubMed ID: 37516270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The North Carolina Experience with Mucopolysaccharidosis Type I Newborn Screening.
    Taylor JL; Clinard K; Powell CM; Rehder C; Young SP; Bali D; Beckloff SE; Gehtland LM; Kemper AR; Lee S; Millington D; Patel HS; Shone SM; Woodell C; Zimmerman SJ; Bailey DB; Muenzer J
    J Pediatr; 2019 Aug; 211():193-200.e2. PubMed ID: 31133280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genotype-phenotype relationships in mucopolysaccharidosis type I (MPS I): Insights from the International MPS I Registry.
    Clarke LA; Giugliani R; Guffon N; Jones SA; Keenan HA; Munoz-Rojas MV; Okuyama T; Viskochil D; Whitley CB; Wijburg FA; Muenzer J
    Clin Genet; 2019 Oct; 96(4):281-289. PubMed ID: 31194252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IDUA mutational profile and genotype-phenotype relationships in UK patients with Mucopolysaccharidosis Type I.
    Ghosh A; Mercer J; Mackinnon S; Yue WW; Church H; Beesley CE; Broomfield A; Jones SA; Tylee K
    Hum Mutat; 2017 Nov; 38(11):1555-1568. PubMed ID: 28752568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Residual α-L-iduronidase activity in fibroblasts of mild to severe Mucopolysaccharidosis type I patients.
    Oussoren E; Keulemans J; van Diggelen OP; Oemardien LF; Timmermans RG; van der Ploeg AT; Ruijter GJ
    Mol Genet Metab; 2013 Aug; 109(4):377-81. PubMed ID: 23786846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pilot newborn screening program for Mucopolysaccharidosis type I in Taiwan.
    Lin SP; Lin HY; Wang TJ; Chang CY; Lin CH; Huang SF; Tsai CC; Liu HL; Keutzer J; Chuang CK
    Orphanet J Rare Dis; 2013 Sep; 8():147. PubMed ID: 24053568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosing lysosomal storage disorders: mucopolysaccharidosis type I.
    Johnson BA; Dajnoki A; Bodamer OA
    Curr Protoc Hum Genet; 2015 Jan; 84():17.17.1-17.17.8. PubMed ID: 25599668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Status of newborn screening and follow up investigations for Mucopolysaccharidoses I and II in Taiwan.
    Chuang CK; Lin HY; Wang TJ; Huang YH; Chan MJ; Liao HC; Lo YT; Wang LY; Tu RY; Fang YY; Chen TL; Ho HC; Chiang CC; Lin SP
    Orphanet J Rare Dis; 2018 May; 13(1):84. PubMed ID: 29801497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Taiwan National Newborn Screening Program by Tandem Mass Spectrometry for Mucopolysaccharidoses Types I, II, and VI.
    Chan MJ; Liao HC; Gelb MH; Chuang CK; Liu MY; Chen HJ; Kao SM; Lin HY; Huang YH; Kumar AB; Chennamaneni NK; Pendem N; Lin SP; Chiang CC
    J Pediatr; 2019 Feb; 205():176-182. PubMed ID: 30409495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Newborn screening in mucopolysaccharidoses.
    Donati MA; Pasquini E; Spada M; Polo G; Burlina A
    Ital J Pediatr; 2018 Nov; 44(Suppl 2):126. PubMed ID: 30442156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The combined use of enzyme activity and metabolite assays as a strategy for newborn screening of mucopolysaccharidosis type I.
    Polo G; Gueraldi D; Giuliani A; Rubert L; Cazzorla C; Salviati L; Marzollo A; Biffi A; Burlina AP; Burlina AB
    Clin Chem Lab Med; 2020 Nov; 58(12):2063-2072. PubMed ID: 32432561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Report of 5 novel mutations of the α-L-iduronidase gene and comparison of Korean mutations in relation with those of Japan or China in patients with mucopolysaccharidosis I.
    Kwak MJ; Huh R; Kim J; Park HD; Cho SY; Jin DK
    BMC Med Genet; 2016 Aug; 17(1):58. PubMed ID: 27520059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel splice site IDUA gene mutation in Tunisian pedigrees with hurler syndrome.
    Chkioua L; Boudabous H; Jaballi I; Grissa O; Turkia HB; Tebib N; Laradi S
    Diagn Pathol; 2018 May; 13(1):35. PubMed ID: 29843745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Report of Five Years of Experience in Neonatal Screening for Mucopolysaccharidosis Type I and Review of the Literature.
    Gragnaniello V; Gueraldi D; Rubert L; Manzoni F; Cazzorla C; Giuliani A; Polo G; Salviati L; Burlina A
    Int J Neonatal Screen; 2020 Nov; 6(4):. PubMed ID: 33147872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucopolysaccharidosis I: Alpha-L-Iduronidase mutations in three Tunisian families.
    Laradi S; Tukel T; Erazo M; Shabbeer J; Chkioua L; Khedhiri S; Ferchichi S; Chaabouni M; Miled A; Desnick RJ
    J Inherit Metab Dis; 2005; 28(6):1019-26. PubMed ID: 16435195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pilot study of newborn screening for six lysosomal storage diseases using Tandem Mass Spectrometry.
    Elliott S; Buroker N; Cournoyer JJ; Potier AM; Trometer JD; Elbin C; Schermer MJ; Kantola J; Boyce A; Turecek F; Gelb MH; Scott CR
    Mol Genet Metab; 2016 Aug; 118(4):304-9. PubMed ID: 27238910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Newborn screening of mucopolysaccharidosis type I.
    Burlina AB; Gragnaniello V
    Crit Rev Clin Lab Sci; 2022 Jun; 59(4):257-277. PubMed ID: 35037566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An algorithm to predict phenotypic severity in mucopolysaccharidosis type I in the first month of life.
    Kingma SD; Langereis EJ; de Klerk CM; Zoetekouw L; Wagemans T; IJlst L; Wanders RJ; Wijburg FA; van Vlies N
    Orphanet J Rare Dis; 2013 Jul; 8():99. PubMed ID: 23837464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular genetics of mucopolysaccharidosis type I: diagnostic, clinical, and biological implications.
    Scott HS; Bunge S; Gal A; Clarke LA; Morris CP; Hopwood JJ
    Hum Mutat; 1995; 6(4):288-302. PubMed ID: 8680403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and characterization of 20 novel pathogenic variants in 60 unrelated Indian patients with mucopolysaccharidoses type I and type II.
    Uttarilli A; Ranganath P; Matta D; Md Nurul Jain J; Prasad K; Babu AS; Girisha KM; Verma IC; Phadke SR; Mandal K; Puri RD; Aggarwal S; Danda S; Sankar VH; Kapoor S; Bhat M; Gowrishankar K; Hasan AQ; Nair M; Nampoothiri S; Dalal A
    Clin Genet; 2016 Dec; 90(6):496-508. PubMed ID: 27146977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.